| Literature DB >> 28506251 |
Supram Hosuru Subramanya1, Nawal Kishor Sharan2, Bharat Prasad Baral2, Deependra Hamal2, Niranjan Nayak2, Peralam Yegneswaran Prakash3, Brijesh Sathian2, Indira Bairy4, Shishir Gokhale2.
Abstract
BACKGROUND: Poultry farming and consumption of poultry (Gallus gallus domesticus) meat and eggs are common gastronomical practices worldwide. Till now, a detailed understanding about the gut colonisation of Gallus gallus domesticus by yeasts and their virulence properties and drug resistance patterns in available literature remain sparse. This study was undertaken to explore this prevalent issue.Entities:
Keywords: Antifungal resistance; Gastrointestinal colonisation; Poultry guano; Virulence factor; Yeast
Mesh:
Substances:
Year: 2017 PMID: 28506251 PMCID: PMC5433169 DOI: 10.1186/s12866-017-1024-4
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Locations of Kaski district from where samples were collected (highlighted in blue) http://lgcdp.gov.np/node/363
Biofilm and other virulence determinants of yeast isolated from Gallus gallus domesticus droppings
| Virulence determinants | Yeast isolates | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
| Colony count (CFU/g) | Min = 2 × 106 Max = 7 × 106 M = 5 × 106 | Min = 2.7 × 106 Max = 1.2 × 107 M = 6.6 × 106 | Min = 3 × 106 Max = 2.3 × 107 M = 1.1 × 107 | Min = 1.1× ×106 Max = 1.2 × 107 M = 5 × 106 | Min = 3 × 106 Max = 1.9 × 107 M = 9 × 106 | Min = 3 × 106 Max = 1.6 × 107 M = 9.5 × 106 | Load = 1.1 × 107 | Min = 1.1 × 106 Max = 5 × 106 M = 3 × 106 | Min = 3 × 106 Max = 1.6 × 107 M = 8.3 × 106 | Min = 2 × 106 Max = 4 × 106 M = 3.3 × 106 | Min = 4 × 105 Max = 5 × 106 M = 3.3 × 106 | Load = 2 × 106 | |
| Biofilm Positive | 5 | 4 | 1 | 10 | 7 | 0 | 0 | 1 | 3 | 4 | 3 | 0 | |
| Biofilm Negative | 5 | 4 | 5 | 19 | 5 | 2 | 1 | 2 | 0 | 0 | 6 | 1 | |
| DNAse Positive | 1 | 3 | 0 | 4 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | |
| DNAse Negative | 9 | 5 | 6 | 25 | 11 | 2 | 1 | 3 | 2 | 4 | 8 | 1 | |
| Hemolysin Positive | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Hemolysin Negative | 10 | 8 | 6 | 29 | 12 | 2 | 1 | 3 | 3 | 4 | 9 | 1 | |
| Esterase | Pz valuea | ||||||||||||
| Very strong | ≤0.69 | 6 | 1 | 0 | 5 | 2 | 0 | 1 | 2 | 1 | 1 | 0 | 0 |
| Strong | 0.70–0.79 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mild | 10–19.9 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Weak | 0.90–0.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Negative | >/= 1.0 | 4 | 7 | 6 | 24 | 8 | 2 | 0 | 1 | 2 | 3 | 8 | 0 |
| Aspartyl proteinase | Pz valuea | ||||||||||||
| Very strong | ≤0.69 | 2 | 0 | 1 | 8 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong | 0.70–0.79 | 2 | 1 | 1 | 3 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| Mild | 0.80–0.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Weak | 0.90–0.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Negative | >/= 1.0 | 6 | 7 | 4 | 18 | 12 | 1 | 0 | 1 | 2 | 4 | 8 | 0 |
| Phospholipase | Pz valuea | ||||||||||||
| Very strong | ≤0.69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Strong | 0.70–0.79 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mild | 10–19.9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Weak | 0.90–0.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Negative | >/= 1.0 | 8 | 7 | 6 | 29 | 2 | 2 | 1 | 3 | 2 | 4 | 9 | 1 |
| CSH | % | ||||||||||||
| Very strong | >30 | 6 | 5 | 4 | 12 | 10 | 1 | 0 | 2 | 2 | 2 | 6 | 0 |
| Strong | 20–29.9 | 2 | 0 | 0 | 4 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Mild | 10–19.9 | 1 | 2 | 0 | 5 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Weak | 0.1–9.99 | 1 | 1 | 2 | 8 | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 0 |
| Negative | < 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SOD | H2O2 mMol | ||||||||||||
| Very strong | 50 | 4 | 3 | 1 | 11 | 5 | 0 | 1 | 2 | 2 | 4 | 5 | 0 |
| Strong | 40 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
| Strong | 30 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mild | 20 | 0 | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
| Mild | 10 | 2 | 2 | 2 | 4 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Weak | 5 | 2 | 0 | 1 | 6 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 |
| Negative | No growth | 0 | 0 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
aPz value: the ratio of the colony diameter to the diameter of the activity halo; Min-minimum; Max-maximum; M-mean value; ccommercial G domesticus; ddomesticated G domesticus
Fig. 2A box plot representation of the CFU/g median values of different yeasts isolated from Gallus gallus domesticus. Legend: 1: C. albicans, 2: D. catenulate (C catenulate), 3: C. tropicalis, 4: D. hansenii (C. famata), 5: S. catenata (C ciferrii), 6: C. pintolopesii, 7: Cryptococcus macerans, 8: Trichosporon spp. 9: G candidum 10: Cystobasidium minuta (Rhodotorula minuta), 12: C parapsilosis, 13: C. acidothermophilum (C. krusei)
Spearman’s correlation coefficient for in-vitro virulence factor measurements of yeast isolate
| Assay Parameters | DNAse (Pz) | Biofilm (OD) | CSH (%) | SOD (mMol) | Proteniase (Pz) | Phospholipase (Pz) | Esterase (Pz) | |
|---|---|---|---|---|---|---|---|---|
| DNAse (Pz) | Spearman’s Correlation | 1 | 0.133 | 0.158 | 0.035 | −0.054 | 0.240 | 0.188 |
|
| -- | 0.216 | 0.141 | 0.749 | 0.615 | 0.024 | 0.079 | |
| Biofilm (OD) | Spearman’s Correlation | 0.133 | 1 | −0.008 | −0.023 | 0.140 | 0.126 | 0.002 |
|
| 0.216 | -- | 0.941 | 0.835 | 0.195 | 0.243 | 0.983 | |
| CSH (%) | Spearman’s Correlation | 0.158 | −0.008 | 1 | −0.029 | 0.020 | 0.059 | 0.237a |
|
| 0.141 | 0.941 | -- | 0.787 | 0.850 | 0.586 | 0.026 | |
| SOD (mMol) | Spearman’s Correlation | 0.035 | −0.023 | −0.029 | 1 | −0.187 | −0.092 | 0.101 |
|
| 0.749 | 0.835 | 0.787 | -- | 0.080 | 0.396 | 0.351 | |
| Proteinase (Pz) | Spearman’s Correlation | −0.054 | 0.140 | 0.020 | −0.187 | 1 | 0.407b | 0.127 |
|
| 0.615 | 0.195 | 0.850 | 0.080 | -- | 0.000 | 0.237 | |
| Phospholipase (Pz) | Spearman’s Correlation | 0.240a | 0.126 | 0.059 | −0.092 | 0.407b | 1 | 0.095 |
|
| 0.024 | 0.243 | 0.586 | 0.396 | 0.000 | -- | 0.381 | |
| Esterase (Pz) | Spearman’s Correlation | 0.188 | 0.002 | 0.237 | 0.101 | 0.127 | 0.095 | 1 |
|
| 0.079 | 0.983 | 0.026 | 0.351 | 0.237 | 0.381 | -- | |
aCorrelation is significant at the 0.05 level; bCorrelation is significant at the 0.01 level
In vitro activity of antifungal drugs against planktonic cells
| Species (No. of isolates) | MIC (μg/ml) of Planktonic cells | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fluconazole | Amphotericin B | Voriconazole | Caspofungin | |||||||||||||
| Interval | MIC 50 | MIC 90 | GM | Interval | MIC50 | MIC90 | GM | Interval | MIC50 | MIC90 | GM | Interval | MIC 50 | MIC90 | GM | |
|
| 0.03–16 | 4.5 | 16 | 2 | 0.03–8 | 0.37 | 2.6 | 0.4 | 0.125–8 | 0.37 | 8 | 0.61 | 0.03–0.5 | 0.125 | 0.5 | 0.12 |
|
| 0.5–16 | 5 | 16 | 3.3 | 0.06–16 | 0.25 | 4.9 | 0.27 | 0.125–0.5 | 0.5 | 0.5 | 0.29 | 0.0625–0.5 | 0.125 | 0.325 | 0.14 |
|
| 4–16 | 8 | 12 | 7.12 | 0.03–16 | 2.5 | 16 | 1 | 0.125–8 | 0.5 | 6 | 0.89 | 0.125–.25 | 0.125 | 0.25 | 0.15 |
|
| 0.03–16 | 1 | 9.6 | 0.952 | 0.03–16 | 0.25 | 1 | 0.28 | 0.06–1 | 0.25 | 0.5 | 0.20 | 0.03–1 | 0.125 | 0.5 | 0.17 |
|
| 0.13–16 | 4 | 8 | 2.5 | 0.03–16 | 0.18 | 14.8 | 0.35 | 0.125–1 | 0.5 | 0.5 | 0.37 | 0.125–1 | 0.25 | 0.25 | 0.21 |
|
| 0.03–8 | - | - | 0.49 | 0.03–1 | - | - | 0.17 | 0.125–0.5 | - | - | 0.25 | 0.5–0.5 | - | - | 0.5 |
|
| 2 | - | - | - | 0.5 | - | - | - | 0.25 | - | - | - | 0.0625 | - | - | - |
|
| 8–16 | - | - | 12.7 | 0.03–0.25 | - | - | 0.09 | 0.062–4 | - | - | 0.39 | 0.031–0.125 | - | - | 0.06 |
|
| 0.5–1 | - | - | 0.79 | 0.13–0.5 | - | - | 0.31 | 0.5–4 | - | - | 1 | 0.0313–0.5 | - | - | 0.15 |
|
| 0.03–16 | 4 | 9.6 | 2.92 | 0.25–16 | 1 | 9.6 | 1.36 | 0.120.5 | 0.25 | 0.5 | 0.27 | 0.062–0.5 | 0.125 | 0.3 | 0.14 |
|
| 0.5–8 | - | - | 2 | 0.03–2 | - | - | 0.29 | 0.125–0.5 | - | - | 0.29 | 0.031–0.25 | - | - | 0.14 |
|
| 1 | - | - | - | 0.125 | - | - | - | 0.25 | - | - | - | 0.125 | - | - | - |
MIC50: Minimal inhibitory concentration capable of inhibiting the growth of 50% of isolates; MIC90: Minimal inhibitory concentration capable of inhibiting the growth of 90% of isolates; GM: Geometric Mean MIC
In vitro activity of antifungal drugs against biofilm forming cells
| Yeast species (No. of isolates) | MIC (mg/ml) of biofilm forming cells | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fluconazole | Amphotericin B | Voriconazole | Caspofungin | |||||||||||||
| Interval | MIC50 | MIC90 | GM | Interval | MIC50 | MIC90 | GM | Interval | MIC50 | MIC90 | GM | Interval | MIC50 | MIC90 | GM | |
|
| 8–256 | 128 | 204.8 | 64 | 0.5–4 | 1 | 3.2 | 1.3 | 0.5–8 | 4 | 8 | 2.29 | 0.062–0.5 | 0.125 | 0.5 | 0.18 |
|
| 16–256 | - | - | 45.2 | 0.5–8 | - | - | 2 | 1–2 | - | - | 1.18 | 0.125–0.5 | - | - | 0.25 |
|
| 128 | - | - | - | 16 | - | - | - | 1 | - | - | - | 8 | - | - | - |
|
| 8–512 | 33 | 166.4 | 42.4 | 0.5–16 | 1 | 5.2 | 1.62 | 0.125–4 | 0.5 | 1.3 | 0.65 | 0.125–1 | 0.5 | 0.5 | 0.37 |
|
| 8–512 | 64 | 281.6 | 47.5 | 1–16 | 2 | 8 | 2.2 | 0.5–16 | 0.5 | 7 | 1 | 0.5–4 | 0.5 | 2.2 | 0.74 |
|
| 128 | - | - | - | 1 | - | - | - | 8 | - | - | - | 0.0625 | - | - | - |
|
| 16–256 | - | - | 50.7 | 4–16 | - | - | 6.3 | 0.5–1 | - | - | 0.62 | 0.125–0.5 | - | - | 0.31 |
|
| 16–128 | - | - | 53.8 | 1–2 | - | - | 1.18 | 0.5–1 | - | - | 0.59 | 0.125–1 | - | - | 0.42 |
|
| 8–32 | - | - | 16 | 1–8 | - | - | 2.5 | 1–8 | - | - | 2 | 0.125–1 | - | - | 0.39 |